2.2. Modification of the spontaneous augmentation of NaV1.9 by PKA and PKC
As previously described [
11,
17], the peak amplitude of the Na
V1.9 current remarkably increased during conventional whole-cell recording with control pipette solution. As shown in , the peak amplitude of the Na
V1.9 current gradually increased up to 18.7 ± 5.0-fold of the initial value (n = 10), and then diminished towards the initial value. The total duration of the spontaneous augmentation of Na
V1.9 was 12.4 ± 1.7 min (n = 10). In addition, activation and inactivation kinetics of this current did not change during the spontaneous augmentation of Na
V1.9 ().
summarizes the intensity changes of the spontaneous augmentation of NaV1.9, which were induced by compounds added to the pipette solution. In the presence of a PKA activator, forskolin (10 μM), the intensity of the spontaneous augmentation of NaV1.9 was significantly attenuated (2.1 ± 0.5-fold: n = 10). Although a PKA inhibitor, H-89 (10 μM). alone had no detectable effect on the intensity of the spontaneous augmentation of NaV1.9 (21.1 ± 7.3-fold: n = 10), the effect of forskolin was significantly inhibited by treatment with H-89 (17.3 ± 3.5-fold: n = 10). A PKC activator, PMA (100 nM), had significant suppressive effect on the intensity of the augmentation of NaV1.9 (2.0 ± 0.3-fold: n = 10). In the presence of a PKC inhibitor, calphostin C (100 nM), the effect of PMA on the augmentation of NaV1.9 was significantly inhibited (14.2 ± 2.8-fold: n = 10). Similarly to H-89, calphostin C alone had no discernable effect on the spontaneous augmentation of NaV1.9 (11.3 ± 4.4-fold: n = 10).
2.4. The effect of PMA on the h∞ curve for the NaV1.9 current is reproducible under nystatin-perforated patch clamp recording
The spontaneous augmentation of Na
V1.9 was prevented by using nystatin-perforated patch clamp recording [
11]. Therefore, we further examined the effect of forskolin and PMA on the
h∞ (voltage dependence of steady-state inactivation) curve for the Na
V1.9 current in such a situation. The Na
V1.9 current was evoked by
VT to 0 mV after various
VPREs steps ranging from −120 mV to 10 mV in 10-mV steps for 3 s (see diagram of ). shows
h∞ curves for the Na
V1.9 current before (control) and after application of 100 nM PMA or 10 μM forskolin for 10 min. The
h∞ curves were fitted to the Boltzmann equation:
Where I is the peak amplitude of the NaV1.9 current obtained by VT, Imax is the peak amplitude of the NaV1.9 current evoked by VC, V1/2 is the half-maximum inactivation voltage, and k is the slope factor. We found significant differences (P < 0.05) between parameters obtained after PMA application (n = 5, V1/2 = −52.1 ± 5.4 mV, k = 5.17 ± 0.44 mV) versus control (n = 4, V1/2 = −44.7 ± 6.4 mV, k = 3.75 ± 0.15 mV). On the contrary, there was no significant change between values obtained after forskolin application (n = 5, V1/2 = −44.6 ± 2.1 mV, k = 4.44 ± 0.51 mV) from the control.
2.5. Discussion
The expression of the Na
V1.9 current is confined to the subpopulation of primary afferent neurons with a small cell-body diameter similarly to the Na
V1.8 current [
4–
8,
10,
11,
18]. This observation suggests that Na
V1.9 plays an important role in nociception, similar to Na
V1.8. On the other hand, the electrophysiological properties of the Na
V1.9 current differ notably from those of the Na
V1.8 current,
i.e., the Na
V1.9 current has a more hyperpolarized activation threshold, much slower activation and inactivation kinetics, and a more depolarized
h∞ curve [
11,
13]. These observations suggest that the role of Na
V1.9 in nociception may be distinct from that of Na
V1.8.
It was reported that the sustained membrane depolarization (over several hundreds of milliseconds), which is resistant to TTX, is observed in myenteric ganglia [
12]. In addition, we previously observed similar sustained membrane depolarization mediated by Na
V1.9 in small DRG neurons [
13]. The Na
V1.9 current may have facilitatory functions in the generation of action potential. On the other hand,
h∞ curves for other Na
+ currents are more depolarized than that of Na
V1.9 [
11,
13]. Taking into consideration these properties, sustained activation of Na
V1.9 may decrease the availability of other Na
+ channels, and then conversely act to inhibit generation of action potential. Thus, the regulation of membrane potential by Na
V1.9 may be facilitatory or inhibitory to generating an action potential, in a context-dependent manner.
In addition, we observed a sporadic and remarkable increase of the peak amplitude of the Na
V1.9 current followed by decrease of the peak amplitude during whole-cell patch clamp recording (“spontaneous augmentation of Na
V1.9”) [
11]. We previously reported that the spontaneous augmentation of Na
V1.9 was inhibited by recording with the nystatin-perforated patch clamp technique, and in the presence of intracellular ATP [
11,
17]. These results suggest a possible involvement of the intracellular environment in the spontaneous augmentation of Na
V1.9.
Analyses of brain Na
+ channels have shown that the cytoplasmic loop between domains DI and DII of Na
+ channels possesses several shared PKA and PKC phosphorylation sites [
19–
20]. In addition, the inactivation gate has a unique site for PKC phosphorylation [
22,
23]. In fact, activation of PKA reduces the peak amplitude of brain Na
+ channels without the shift of the steady-state properties [
20,
24]. On the other hand, activation of PKC has regulatory effects on skeletal muscle Na
+ channels [
25], brain Na
+ channels [
26] and peripheral nerve Na
+ channel expressed in
Xenopus oocytes [
27]. However, the effects of PKA and PKC on the spontaneous augmentation of Na
V1.9 in sensory neurons have not been investigated.
First, we focused on the effect of PKA on the spontaneous augmentation of NaV1.9. The spontaneous augmentation of NaV1.9 was significantly suppressed in the presence of forskolin, and H-89 significantly inhibited this suppressive effect of forskolin (). These results indicate that the spontaneous augmentation of NaV1.9 is suppressed by activation of PKA. It is well known that the amplitude of Na+ current is strongly affected by steady-state inactivation of the channel. However, forskolin did not change the h∞ curve parameters for the NaV1.9 current in comparison with the control ( and ). This suggests that inhibition of the spontaneous augmentation of NaV1.9 by PKA activation was not due to the hyperpolarizing shift of the h∞ curve for the NaV1.9 current.
Next, we focused on the effect of PKC on the spontaneous augmentation of NaV1.9. PMA significantly reduced the intensity of augmentation, and the effect of PMA was significantly suppressed by Calphostin C (). However, application of PMA induced the hyperpolarizing shift of the voltage dependence of inactivation for the NaV1.9 current. Thus, apparent suppression of the spontaneous augmentation of NaV1.9 by PMA was largely due to hyperpolarizing shift of the h∞ curve for the NaV1.9 current.
A similar phenomenon has also been reported by Baker
et al., who showed that intracellular GTP [
28] or activation of PKC [
29] induces the up-regulation of the Na
V1.9 current. There are distinct dissimilarities between the up-regulation reported by Baker
et al. and the spontaneous augmentation of Na
V1.9 described in the present study and also in our previous reports [
11,
13,
17]. Namely, (1) the up-regulation reported by Baker
et al. was observed in the presence of intracellular ATP. On the contrary, the spontaneous augmentation of Na
V1.9 in our experiments occurred only in the absence of intracellular ATP. (2) the up-regulation reported by
Baker et al. was mediated by intracellular GTP or activation of PKC. On the other hand, we find that intracellular GTP has no effect on the spontaneous augmentation of Na
V1.9 (unpublished data). (3)
Baker et al. showed only an increment of peak amplitude of the Na
V1.9 current, and did not show the entire time course of the phenomenon [
28,
29]. The spontaneous augmentation of Na
V1.9 was composed of an increase and a subsequent decrease of peak amplitude of the Na
V1.9 current. From these observations, the up-regulation reported by
Baker et al. may be distinct from the spontaneous augmentation of Na
V1.9 in our studies.
A recent behavioral study showed that the PKA inhibitor, H-89, suppresses bee venom-induced mechanical hyperalgesia in rats [
30], and the activation of PKA is conductive to the inflammatory mechanical hyperalgesia [
31,
32]. In addition, activity of specific PKC isozymes is increased in inflammatory-pain models in rats [
33–
36]. From these observations, the Na
V1.9 channel may be regulated not to increase the amplitude of the Na
V1.9 current,
i.e., the spontaneous augmentation of Na
V1.9 under pathological condition by PKA and/or PKC activation.
Recently, it has been reported that Na
V1.9 underlies nociceptive behavior after peripheral inflammation in Na
V1.9 KO mice [
37]. In addition, histochemical study on Na
V1.9 channel proteins in axons of normal and complete Freund’s adjuvant-inflamed rats showed significant decrease of the proportion of Na
V1.9-labeled unmyelinated axons, and no change in the proportion of labeled myelinated axons following inflammation [
18]. Taken together, the Na
V1.9 current contributes to pain signaling, and may alter under pathophysiological conditions.